Our cross-sectional analysis demonstrated that CSF neurofilament levels are significantly associated with disease progression in ALS, particularly NfM showed the strongest elevation in intermediate-to-fast progressors, followed by NfL and NfH. The gene discussed is NEFL; the disease is amyotrophic lateral sclerosis.